Fresenius Vascular Care

Fresenius Vascular Care (FVC) is a leading national provider of specialized vascular services, offering minimally invasive treatments for a wide range of vascular disorders. The company's focus on exceptional clinical outcomes and customer service is evident in their state-of-the-art outpatient centers, where expert care is provided in a patient-friendly environment. FVC's expertise in vascular access and interventional procedures such as revascularization for PAD and embolization of uterine fibroids has positioned them as pioneers in the field. The company has established partnerships with top-tier physicians specializing in advanced interventional techniques, ensuring that patients receive care from highly experienced practitioners. With a commitment to excellence, FVC's leadership team aims to deliver integrated care with a focus on optimal patient outcomes. Additionally, FVC is affiliated with Fresenius Medical Care North America, the world's largest provider of dialysis services and products. Since its founding in 2005, FVC has garnered investment interest, with the most recent being a Venture - Series Unknown round on 19 October 2023. While the specific details of the investors for this round are not provided, FVC's alignment with top-tier medical practices and its affiliation with a global leader in dialysis services position it as an attractive prospect for potential investors seeking opportunities in the Health Care industry.